Kazia Therapeutics Limite... (KZIA)
NASDAQ: KZIA
· Real-Time Price · USD
6.56
0.25 (3.96%)
At close: Oct 03, 2025, 3:59 PM
6.42
-2.14%
After-hours: Oct 03, 2025, 07:51 PM EDT
3.96% (1D)
| Bid | 6.03 |
| Market Cap | 3.77M |
| Revenue (ttm) | 2.49M |
| Net Income (ttm) | -23.18M |
| EPS (ttm) | -29.4 |
| PE Ratio (ttm) | -0.22 |
| Forward PE | -651 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 6.8 |
| Volume | 83,649 |
| Avg. Volume (20D) | 314,119 |
| Open | 6.25 |
| Previous Close | 6.31 |
| Day's Range | 6.20 - 6.65 |
| 52-Week Range | 2.86 - 39.05 |
| Beta | 2.15 |
| Ex-Dividend Date | n/a |
About KZIA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KZIA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KZIA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 days ago
-7.88%
KZIA stock has given up its prior gain. Kazia Ther...
Unlock content with
Pro Subscription
3 days ago
-7.88%
Kazia Therapeutics shares are trading higher after the company reported an 86% tumor burden reduction in a triple-negative breast cancer patient treated with paxalisib in combination regimen.
